Breaks Categories: Stock Spotlights

WednesdayJul 17, 2019 2:15 pm

CBDNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Positioned to Profit as New Hemp Regulations Facilitate Widespread Cultivation in California

Green Hygienics Holdings (OTCQB: GRYN), a full-scope, science-driven, premium-cannabis cultivation and branding enterprise, is poised to capitalize in the growing California hemp market as new industrial hemp regulations establish registration procedures for cultivators in the state (http://cnw.fm/3Hj8R). The goal of the new program is to enable the widespread cultivation of hemp across California. An article discussing the company reads, “Green Hygienics became registered to cultivate industrial hemp in San Diego County in June 2019. The science-driven, premium-cannabis cultivation company announced that it has secured the required permits from the County of San Diego Department of Agriculture, Weights and Measures (http://cnw.fm/lB5pM). .…

Continue Reading

WednesdayJul 17, 2019 2:07 pm

CBDNewsBreaks – Earth Science Tech Inc. (ETST) Subsidiary Establishes Position as Global Leader in CBD Industry

Florida-based biotechnology company Earth Science Tech (OTCQB: ETST), through its wholly owned subsidiaries, is focused on establishing its role as a global leader in the CBD space. A recent article discussing the company reads, “The company’s Cannabis Therapeutics Inc. subsidiary is a biotech firm focusing on CBD research and development for an extensive line of cannabinoid-based pharmaceuticals, nutraceuticals and other products and solutions (http://cnw.fm/pMBx7). The company is working to explore and harness the medicinal power of cannabidiol. Cannabis Therapeutics has a provisional application patent for CBD, and its first projects are centered on developing treatments for breast and ovarian cancers.” To…

Continue Reading

FridayJul 12, 2019 2:51 pm

CBDNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Acquires 49% Interest in Budding Cannabis Industry Disruptor

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, recently reported the completion of its purchase of a 49% interest in Cannova Medical Ltd. The company also holds the option to acquire the remaining 51% interest in Cannova. A recent article discussing the company reads, “Cannova Medical is a provider of innovative solutions for cannabis consumption. Pursuing its interest in investment across all vertically integrated aspects of the cannabis sector, with a focus on strategic revenue generation, Nabis selected Cannova because of its innovative…

Continue Reading

FridayJul 12, 2019 2:11 pm

CBDNewsBreaks – VPR Brands LP (VPRB) Sponsors a Cannabis Voter’s Guide to Presidential Candidates

VPR Brands LP (OTC: VPRB), a market leader specializing in vaporizers and accessories for essential oils, CBD and electronic cigarettes, recently announced the availability of a guide the company sponsored for cannabis voters that details the 2020 presidential candidates. An article discussing the company reads, “‘The time has come to elect a president who’ll establish a nationwide standard for cannabis as a legal substance, distributed through a regulated industry with access to capital markets, with pardons and reparations considered for those who found themselves ahead of the law,’ VPR Brands CEO Kevin Frija stated in a news release. ‘I looked…

Continue Reading

ThursdayJul 11, 2019 3:24 pm

CBDNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Subsidiary Secures Coveted Standard Processing License

Geyser Brands’ (TSX.V: GYSR) wholly owned subsidiary, Apothecary Botanicals, recently achieved a major milestone when it received its standard processing license, enabling Geyser to advance its brands (http://cnw.fm/8FyOi). An article discussing the company reads, “The new license allows Geyser to begin work to extend its cannabidiol products to the regulated Canadian consumer medical market as the company awaits its sales license. The company’s nano-emulsion technology carries oil and hemp terpene-infused benefits quickly and efficiently into the bloodstream for rapid relief of pain while boosting the body’s general abilities with all-natural ingredients. . . . In keeping with its mission to develop…

Continue Reading

ThursdayJul 11, 2019 3:06 pm

CBDNewsBreaks – City View Green Holdings Inc. (CSE: CVGR) Retail Arm Seeks Retail, Financial Investment Partnerships

City View Green Holdings (CSE: CVGR), formerly Icon Exploration Inc., is eyeing a bright future for its shareholders as Budd Hutt, the company’s retail arm, pursues strong financial investment partners and retail partnerships throughout Canada. CVGR holds a 19.9% equity position in Budd Hutt. An article discussing the company reads, “For retail-focused cannabis company Budd Hutt, the addition of brick-and-mortar retail stores would cement the brand and the company in the recreational-cannabis market while it prepares for growth in Ontario and other key markets in the near future. . . . The company expects to announce a retail partnership prior…

Continue Reading

ThursdayJul 11, 2019 2:40 pm

CBDNewsBreaks – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Focuses on Expanding Suite of CBD, Hemp-Derived Products

Vancouver-based cannabis company Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) has been diligently working on a strategic initiative to expand its product offerings. A recent article discussing the company reads, “In March 2019, the company announced that it was expanding its offerings through the introduction of Pure and Pure Plus tinctures. Both feature hemp-derived CBD, hemp-seed oil and milk thistle. The tinctures provide relief from inflammation and support for healthy liver and heart function. . . . Wildflower announced that it will continue working on new releases as a part of the company’s ongoing product development efforts. The company has also…

Continue Reading

WednesdayJul 10, 2019 3:14 pm

CBDNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Obtains Lucrative, Multiyear Hemp Purchase Order

Green Hygienics Holdings (OTCQB: GRYN), a full-scope, science-driven, premium-cannabis cultivation and branding enterprise, recently entered a multiyear purchase order for the sale of hemp to U.S. Tobacco de Mexico (http://cnw.fm/c5hA3). An article discussing the company reads, “The lucrative five-year contract will require Green Hygienics to deliver $56.4 million worth of hemp flower to the Tijuana, Mexico-based firm for use in its production lines. . . . U.S. Tobacco de Mexico is a Tijuana-based tobacco and cigarette product importer. Its excellent management team and global positioning capabilities will provide various opportunities, making the partnership an exciting one, Green Hygienics Vice President…

Continue Reading

WednesdayJul 10, 2019 3:00 pm

CBDNewsBreaks – Earth Science Tech Inc. (ETST) Subsidiary Advancing Women’s Wellbeing

Florida-based biotechnology company Earth Science Tech (OTCQB: ETST), through its wholly owned subsidiaries, is focused on helping women by providing ways to assess and treat sexually transmitted infections (“STI”). A recent article discussing the company reads, “Subsidiary Earth Science Pharmaceutical is committed to bringing low-cost, noninvasive testing processes and vaccines for sexually transmitted infections to market to help women improve the quality of their lives. The company’s first medical device, Hygee, is a home kit designed as a modified panty liner to allow for the self-collection of a gynecological specimen that can be tested for two types of infections —…

Continue Reading

WednesdayJul 10, 2019 2:15 pm

CBDNewsBreaks – Why Willow Biosciences Inc. (CSE: WLLW) Is ‘One to Watch’

Alberta, Canada-based Willow Biosciences (CSE: WLLW) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. A recent article discussing Willow Biosciences reads, “The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by chief scientific…

Continue Reading